⚠ Evidence warning: Clinical trials or other evidence do not support the claims that elderberry lowers blood pressure or uric acid in people. This page keeps it as a report of what people, websites or other media say.
Elderberry — Antioxidant and Cardiovascular Effects
Black elderberry (Sambucus nigra) has one of the highest measured oxygen radical absorbance capacity (ORAC) values of any fruit — ranking with aronia (chokeberry), blackcurrant, and wild blueberry at the top of the polyphenol antioxidant hierarchy. The dominant active anthocyanin is cyanidin-3-glucoside (C3G), joined by cyanidin-3-sambubioside and a constellation of supporting flavonols (quercetin, rutin) and phenolic acids (chlorogenic, p-coumaric, ferulic). Beyond the radical-scavenging chemistry, these compounds activate the Nrf2 transcription factor to upregulate endogenous antioxidant enzymes, inhibit low-density lipoprotein (LDL) oxidation, are proposed to modestly lower blood pressure through endothelial nitric oxide enhancement, and reduce serum uric acid in animal studies; the two controlled elderberry trials that measured blood lipids found no significant change. The cardiovascular evidence base remains preliminary — small trials of 34 and 52 people with small or no measurable effects, no large outcome trials. This page maps the antioxidant pharmacology in detail, walks through the cardiovascular pilot data with honest acknowledgment of its limitations, and contextualizes elderberry within the broader anthocyanin-rich-foods cardiovascular literature.
Table of Contents
- Oxygen Radical Absorbance Capacity Ranking — Where Elderberry Sits in the Polyphenol Hierarchy
- Cyanidin-3-Glucoside Chemistry
- Direct Radical Scavenging Mechanism
- Nrf2 Activation and Endogenous Antioxidant Induction
- Low-Density Lipoprotein Oxidation and Atherosclerosis
- Blood Pressure Pilot Data
- Lipid Profile Pilot Trials
- Endothelial Function and Nitric Oxide
- Uric Acid and Xanthine Oxidase Inhibition
- Elderberry in the Broader Anthocyanin Cardiovascular Literature
- Key Research Papers
- Connections
- Featured Videos
Oxygen Radical Absorbance Capacity Ranking — Where Elderberry Sits in the Polyphenol Hierarchy
The oxygen radical absorbance capacity (ORAC) assay measures a food's ability to scavenge peroxyl radicals in vitro. Although the U.S. Department of Agriculture (USDA) discontinued its oxygen radical absorbance capacity database in 2012 (citing that in vitro oxygen radical absorbance capacity values do not reliably predict in vivo antioxidant effect), the assay remains a useful comparative chemistry index for raw polyphenol antioxidant capacity. Published oxygen radical absorbance capacity values for raw fresh black elderberry range from approximately 14,700 to 22,000 µmol TE per 100 g — placing it among the highest-ORAC fruits ever measured.
For comparative context:
- Aronia (chokeberry): ~16,000-20,000 µmol TE/100g — widely considered the oxygen radical absorbance capacity champion among temperate fruits
- Black elderberry: ~14,700-22,000 µmol TE/100g
- Wild blueberry: ~9,000-13,000 µmol TE/100g
- Blackcurrant: ~7,500-9,500 µmol TE/100g
- Cultivated blueberry: ~6,500 µmol TE/100g
- Blackberry: ~5,300 µmol TE/100g
- Pomegranate: ~4,500 µmol TE/100g
- Apple: ~3,000 µmol TE/100g
- Strawberry: ~3,500 µmol TE/100g
The driver of elderberry's elevated oxygen radical absorbance capacity is the unusually high anthocyanin density per gram of fresh fruit weight — comparable on a per-gram basis to the deepest-colored cultivated berries. The dominant anthocyanin in black elderberry is cyanidin (as the glucoside and sambubioside conjugates), which has slightly higher peroxyl-radical scavenging capacity than delphinidin (blueberry) or pelargonidin (strawberry) under standard oxygen radical absorbance capacity conditions.
The caveat that the U.S. Department of Agriculture itself raised in 2012 deserves to be repeated: a high oxygen radical absorbance capacity value is a chemistry observation, not a clinical outcome. In-vitro radical scavenging does not always translate to in-vivo benefit, particularly because most polyphenols have low oral bioavailability and undergo extensive metabolism that can either preserve or eliminate their antioxidant activity. The clinical relevance of elderberry's oxygen radical absorbance capacity ranking is supported by the cellular and animal studies discussed below, not directly proven by the in-vitro number.
Cyanidin-3-Glucoside Chemistry
Cyanidin-3-glucoside (C3G) is the dominant anthocyanin in black elderberry, accounting for approximately 50-60% of total anthocyanin content (with cyanidin-3-sambubioside accounting for most of the remainder). The cyanidin aglycone is a flavylium cation with hydroxyl groups at the 3', 4', 5, 7, and 3-O-glycoside positions, giving it three of the structural features known to confer high antioxidant activity in flavonoids:
- Catechol (3',4'-dihydroxy) group on the B ring — the single most important structural feature for radical scavenging activity in flavonoids; can donate electrons or hydrogen atoms to quench reactive oxygen species
- Positively charged, fully conjugated flavylium C ring linked to the B ring — allows electron delocalization across the molecule, stabilizing the resulting flavonoid radical after hydrogen donation (cyanidin has no 4-oxo group; that feature belongs to flavonols such as quercetin)
- 3-OH (substituted with glucose in C3G) — the glycosylation reduces lipophilicity and antioxidant chemistry slightly but improves water solubility and stability, which matters for in-vivo activity
The pharmacokinetics of C3G after oral consumption are notoriously challenging. Less than 2% of an oral dose is recovered in plasma as the intact anthocyanin, peaking around 30-60 minutes after ingestion and declining rapidly with a half-life of 1-3 hours. The remainder undergoes:
- Gut microbial degradation to protocatechuic acid (3,4-dihydroxybenzoic acid) — a phenolic acid that retains substantial antioxidant activity and circulates at much higher plasma concentrations than the parent anthocyanin
- Hepatic phase II metabolism to glucuronide and sulfate conjugates of C3G that retain partial antioxidant activity
- Conversion to vanillic acid and ferulic acid via additional microbial and hepatic metabolism — further phenolic acid metabolites with documented antioxidant effects
This metabolic profile means that the clinical antioxidant effect of elderberry C3G is mediated more by the phenolic acid metabolites than by intact C3G. A hypothesis that follows, not yet tested in people: a healthy diverse gut microbiome may amplify the antioxidant benefit of dietary anthocyanins, while disrupted gut flora (post-antibiotic, small intestinal bacterial overgrowth (SIBO), severe inflammatory bowel disease (IBD)) may blunt it.
Direct Radical Scavenging Mechanism
The cyanidin aglycone, like all catechol-containing flavonoids, scavenges reactive oxygen species through three mechanisms operating in parallel:
- Hydrogen atom transfer (HAT) — the catechol -OH groups donate hydrogen atoms to peroxyl, hydroxyl, and superoxide radicals, generating water (for hydroxyl) or stabilized non-radical products (for peroxyl). The resulting flavonoid semiquinone radical is unusually stable due to electron delocalization across the conjugated ring system, so it is far less reactive than the radical it neutralized.
- Single electron transfer (SET) — under different solvent and pH conditions, cyanidin donates an electron rather than a hydrogen atom, generating a flavonoid cation radical and reducing the target radical. The flavonoid cation radical is rapidly resolved by water or other available proton donors.
- Metal chelation — the catechol group binds redox-active metal cations (iron, copper, manganese) and prevents them from catalyzing Fenton reactions that generate hydroxyl radicals from hydrogen peroxide. This is the same mechanism by which EDTA reduces metal-catalyzed oxidative damage in food systems.
Of these three, the metal chelation mechanism is particularly relevant in pathological states like iron overload, hemochromatosis, and atherosclerotic plaque (which accumulates iron and copper). It has been proposed, though not shown in people or animals, that elderberry polyphenols could sequester transition metals in plaque, blunting the Fenton-driven oxidation of low-density lipoprotein that initiates the atherosclerotic cascade.
Nrf2 Activation and Endogenous Antioxidant Induction
Beyond direct radical scavenging, elderberry polyphenols and their metabolites induce the endogenous antioxidant defense system through Nrf2 transcription factor activation. This is the more durable clinical mechanism — direct radical scavenging by orally consumed polyphenols is limited by the low plasma concentrations they reach, but Nrf2-induced upregulation of antioxidant enzymes produces sustained increases in cellular reducing capacity that outlast the plasma anthocyanin concentration.
The Nrf2 mechanism:
- Under basal conditions, Nrf2 is bound in the cytoplasm by its repressor protein Keap1, which directs it for proteasomal degradation
- Reactive oxygen species and electrophiles (including polyphenol metabolites with quinone-like reactivity) modify cysteine residues on Keap1, releasing Nrf2
- Free Nrf2 translocates to the nucleus, dimerizes with small Maf proteins, and binds antioxidant response elements (AREs) in promoter regions of over 200 target genes
- Resulting upregulated proteins include: NAD(P)H quinone oxidoreductase 1 (NQO1), heme oxygenase-1, glutathione-S-transferases, glutathione peroxidase, superoxide dismutase 1 and 2, catalase, glutamate-cysteine ligase (rate-limiting enzyme for glutathione synthesis), thioredoxin reductase
The net effect is increased cellular glutathione, increased phase II detoxification capacity, and increased reducing capacity. The Olejnik 2016 study in cultured human colon cells found that elderberry extract passed through an artificial digestive tract still reduced excess reactive oxygen species inside the cells by 22 percent and oxidative DNA damage by 46 percent, and cut oxidant-induced mutagenicity in a bacterial test by 26 percent; it did not report Nrf2 target-gene expression.
For other Nrf2-activating dietary interventions, see Oxidative Stress and Quercetin.
Low-Density Lipoprotein Oxidation and Atherosclerosis
Atherosclerosis is initiated by oxidation of low-density lipoprotein (LDL) particles in the subendothelial space of arterial walls. Oxidized low-density lipoprotein is taken up by macrophages via scavenger receptors (CD36, SR-A) to form foam cells, the earliest cellular component of the fatty streak that progresses to atherosclerotic plaque. Inhibiting low-density lipoprotein oxidation is therefore a plausible mechanism for preventing or slowing atherosclerosis.
Elderberry anthocyanins and their phenolic acid metabolites have been demonstrated to:
- Inhibit copper-mediated low-density lipoprotein oxidation in vitro at concentrations achievable with normal dietary intake (Abuja et al. 1998 study with elderberry juice extract; the same paper also examined prooxidant activity)
- Reduce malondialdehyde (MDA) formation — a marker of lipid peroxidation — in plasma after elderberry consumption in human pilot studies
- Reduce foam cell formation in cultured macrophages exposed to oxidized low-density lipoprotein pretreated with elderberry extract
This low-density lipoprotein-oxidation-inhibiting effect is shared by many polyphenol-rich foods (red wine, dark chocolate, green tea, pomegranate) and is one of the proposed mechanisms behind the "French paradox" and similar cardiovascular epidemiologic observations. Elderberry contributes to the same general pool of cardioprotective polyphenol intake but has not been specifically shown in long-term outcome trials to reduce atherosclerotic event rates.
Blood Pressure Pilot Data
The blood-pressure effects of elderberry have been studied in small pilot trials and animal models, with consistently modest signal:
- Animal models — spontaneously hypertensive rats fed black elderberry extract show approximately 8-12 mmHg reduction in systolic blood pressure over 4-8 weeks, with similar reductions in diastolic. The effect is dose-dependent and persists during treatment but reverses after discontinuation.
- Mechanism in animals — the blood pressure (BP) reduction is mediated by enhanced endothelial nitric oxide production (via eNOS upregulation and reduced NO inactivation by superoxide), reduced angiotensin-converting enzyme activity, and direct vasodilatory effects of anthocyanin metabolites on vascular smooth muscle.
- Murkovic et al. 2004 — this 2-week randomized, placebo-controlled trial in 34 young healthy volunteers (capsules of 400 mg spray-dried elderberry powder three times a day, equivalent to about 5 ml of juice) measured blood lipids and LDL oxidation; its abstract reports no blood-pressure result. Its lipid results are under Lipid Profile Pilot Trials below.
- Curtis et al. 2009 — the 12-week elderberry-extract trial in 52 postmenopausal women (described below) found no change in blood pressure.
- Subsequent small trials — several small open-label trials of elderberry concentrate or extract in pre-hypertensive and mildly hypertensive adults have shown 3-7 mmHg systolic blood pressure reductions over 4-12 weeks. These are interesting but lack the rigorous double-blind randomized design needed for definitive efficacy claims.
Bottom line: elderberry is not a substitute for antihypertensive medication in established hypertension. There is suggestive evidence that regular elderberry consumption (as juice, extract, or food) may contribute modestly to blood pressure regulation in the same way regular consumption of other anthocyanin-rich foods does (blueberries, blackcurrant, aronia, dark chocolate). For more on blood pressure management, see Hypertension.
Lipid Profile Pilot Trials
The lipid-modifying effects of elderberry are similarly preliminary:
- Animal models — cholesterol-fed rabbits and hamsters supplemented with elderberry extract show 8-15% reductions in total cholesterol and 15-25% reductions in low-density lipoprotein cholesterol over 6-12 weeks, with no significant change in high-density lipoprotein (HDL).
- Murkovic et al. 2004 human pilot — 34 young healthy volunteers took elderberry-extract capsules (400 mg three times a day, equivalent to about 5 ml of juice) or placebo for 2 weeks. Total cholesterol went from 199 to 190 mg/dl on elderberry and from 192 to 196 mg/dl on placebo, a small change that was not statistically significant, and the resistance of LDL to oxidation did not change.
- Qin et al. 2009 anthocyanin trial — while not elderberry-specific, this 12-week double-blind trial gave 120 adults aged 40-65 with abnormal blood lipids berry-derived anthocyanins (160 mg twice daily) or placebo; serum low-density lipoprotein fell 13.6% and high-density lipoprotein rose 13.7%. The anthocyanin dose used was roughly equivalent to the anthocyanin content of 500-600 g/day of fresh elderberry — far higher than feasible from food alone, but achievable with concentrated extract.
- Triglyceride effects are inconsistent across small trials, with no clear signal.
- Curtis et al. 2009 elderberry trial — the one 12-week elderberry trial with cardiovascular markers gave 52 healthy postmenopausal women 500 mg/day of elderberry anthocyanins or placebo. It found no significant change in inflammatory, platelet, lipid or glucose markers or in blood pressure, and liver and kidney tests stayed within clinically acceptable ranges; the authors described the extract as “apparently safe, but ineffective” at altering cardiovascular risk markers in these women.
The Qin 2009 finding is the strongest evidence that anthocyanin-rich foods (including elderberry) may meaningfully improve the lipid profile at high doses. The dose was supraphysiologic compared to ordinary dietary intake but achievable with standardized supplements. Whether typical consumer elderberry syrup doses (1-4 tablespoons/day) produce a similar effect has not been directly tested.
For more on cholesterol management, see Atherosclerosis.
Endothelial Function and Nitric Oxide
Endothelial dysfunction — impaired ability of the vascular endothelium to produce nitric oxide and maintain vasodilation in response to flow or shear stress — is the earliest measurable abnormality in atherosclerotic vascular disease, predating any visible plaque formation by years to decades. Improving endothelial function is therefore a high-value upstream cardiovascular intervention.
The polyphenol-rich-foods literature has consistently shown improvements in flow-mediated dilation (FMD) of the brachial artery after acute and chronic consumption of dark chocolate, blueberries, pomegranate, and red wine. Elderberry has not been studied as extensively in this context, but the available data are consistent with the broader anthocyanin pattern:
- Curtis 2019 blueberry trial — in this 6-month double-blind randomized controlled trial in 115 adults with metabolic syndrome, 1 cup (150 g) of blueberries a day improved FMD by 1.45 percentage points (95% CI 0.83-2.1), which the authors estimated would predict a 12-15% lower cardiovascular risk; half a cup (75 g) a day had no effect, and blood pressure was unaffected.
- Mechanistic studies show that anthocyanin phenolic acid metabolites increase eNOS expression and enzymatic activity in human umbilical vein endothelial cells (HUVEC), and reduce superoxide-mediated NO scavenging via Nrf2-driven upregulation of superoxide dismutase.
- Direct elderberry endothelial trials are limited — this is a gap in the evidence base that warrants attention.
- Teets 2024 elderberry juice trial — in a randomized, placebo-controlled crossover trial, 18 overweight or obese adults without chronic illness drank elderberry juice twice daily for one week. Blood glucose after a test meal was significantly lower, and fat burning (fat oxidation) during the meal test and 30 minutes of moderate exercise was higher, than on placebo; gut bacteria shifted, with more Faecalibacterium and Bifidobacterium. Artery function was not measured.
The clinical implication: elderberry consumption likely contributes to the same general "polyphenol-rich foods improve endothelial function" benefit that has been demonstrated for related dark-colored fruits, but the magnitude of effect specifically attributable to elderberry consumption (vs. blueberries, blackcurrant, pomegranate) is not well-quantified.
Uric Acid and Xanthine Oxidase Inhibition
An interesting and under-publicized cardiovascular angle on elderberry is its effect on uric acid. Elevated serum uric acid (hyperuricemia) is independently associated with hypertension, cardiovascular disease, kidney disease, and metabolic syndrome — possibly via uric-acid-driven endothelial dysfunction. Xanthine oxidase, the enzyme that produces uric acid in the final step of purine catabolism, is also a major source of superoxide radical generation, linking uric acid metabolism to oxidative stress.
Several lines of evidence suggest elderberry polyphenols can modestly inhibit xanthine oxidase and reduce uric acid:
- In vitro — elderberry extract dose-dependently inhibits xanthine oxidase enzyme activity with IC50 values in the low microgram-per-mL range — comparable to or weaker than allopurinol but achievable with consumed extract
- Animal studies — in a 2016 study, rats fed cadmium or lead with freeze-dried elderberry making up 5% of their diet had significantly lower serum uric acid than rats fed the same metals without elderberry (Kopéć 2016). Reductions of 20-35% in rats and mice with diet-induced hyperuricemia, with concurrent reduction in serum oxidative stress markers, are also reported.
- Human data — no published human study of elderberry and uric acid was found; the claim that daily elderberry extract lowers uric acid in people rests on the animal work above.
No study has compared elderberry with allopurinol or febuxostat, the drugs used to lower uric acid in gout, and the uric-acid evidence for elderberry so far comes from animals.
For more on the uric acid / oxidative stress / cardiovascular nexus, see Gout and Oxidative Stress.
Elderberry in the Broader Anthocyanin Cardiovascular Literature
Elderberry should be understood as one member of the larger anthocyanin-rich foods category in the cardiovascular epidemiologic literature. Large prospective cohort studies (Health Professionals Follow-up Study, Nurses' Health Study, EPIC-Norfolk, Rotterdam Study) have examined anthocyanin intake from any source, and single studies differ. In the Nurses' Health Study II (93,600 women aged 25-42), the highest anthocyanin intake was linked to fewer heart attacks (hazard ratio 0.68, 95% CI 0.49-0.96). In the Health Professionals Follow-up Study (43,880 men), higher intake was not associated with total or fatal heart attacks, only borderline with nonfatal ones (hazard ratio 0.87, 0.75-1.00), and not with stroke. Pooled analyses comparing the highest with the lowest intake found:
- Hypertension: 8% lower risk (2026 review of cohorts in healthy people)
- Coronary heart disease: relative risk (RR) 0.83 (95% CI 0.72-0.95) (Xu 2021); heart attacks 18% lower (2026 review)
- Type 2 diabetes: 11% lower risk (2026 review)
- Total cardiovascular disease: relative risk 0.73 (0.55-0.97) (Xu 2021), 26% lower (2026 review); cardiovascular deaths: relative risk 0.91 (0.87-0.96) (Xu 2021), 9% lower (2026 review)
- Stroke: unaffected (2026 review)
In the trials pooled by Xu 2021, neither purified anthocyanins nor anthocyanin-rich berries improved blood pressure or flow-mediated dilation; the 2026 review, limited to healthy people, found improved flow-mediated dilation but no change in lipids, blood pressure or glucose.
The pooled effect sizes are modest, and cohort studies show association rather than proof of cause. The total anthocyanin intake needed to produce these effects is approximately 30-100 mg/day — achievable with 50-150 g of fresh elderberry, blueberry, blackcurrant, blackberry, pomegranate, or any combination. Elderberry is one of the most concentrated dietary sources, making relatively small servings (1-2 tablespoons of syrup or 30-50 g of cooked fruit) a meaningful contribution; a Centers for Disease Control and Prevention report notes that uncooked berries may produce nausea (see Preparation and Safety) to total anthocyanin intake.
Elderberry is not a cardiovascular drug. It is one contributor to the anthocyanin-rich dietary pattern that the cohort studies above associate with fewer heart attacks and less cardiovascular disease; no study has tested elderberry itself against cardiovascular events.
Key Research Papers
- Wu X, Beecher GR, Holden JM, Haytowitz DB, Gebhardt SE, Prior RL (2006). Concentrations of anthocyanins in common foods in the United States and estimation of normal consumption. Journal of Agricultural and Food Chemistry 54(11):4069-75. — PubMed PMID: 16719536
- Abuja PM, Murkovic M, Pfannhauser W (1998). Antioxidant and prooxidant activities of elderberry (Sambucus nigra) extract in low-density lipoprotein oxidation. Journal of Agricultural and Food Chemistry 46(10):4091-4096. — doi:10.1021/jf980296g
- Murkovic M, Abuja PM, Bergmann AR, Zirngast A, Adam U, Winklhofer-Roob BM, Toplak H (2004). Effects of elderberry juice on fasting and postprandial serum lipids and low-density lipoprotein oxidation in healthy volunteers: a randomized, double-blind, placebo-controlled study. European Journal of Clinical Nutrition 58(2):244-9. — PubMed PMID: 14749743
- Curtis PJ, Kroon PA, Hollands WJ, Walls R, Jenkins G, Kay CD, Cassidy A (2009). Cardiovascular disease risk biomarkers and liver and kidney function are not altered in postmenopausal women after ingesting an elderberry extract rich in anthocyanins for 12 weeks. Journal of Nutrition 139(12):2266-71. — PubMed PMID: 19793846
- Qin Y, Xia M, Ma J, Hao Y, Liu J, Mou H, Cao L, Ling W (2009). Anthocyanin supplementation improves serum LDL- and HDL-cholesterol concentrations associated with the inhibition of cholesteryl ester transfer protein in dyslipidemic subjects. American Journal of Clinical Nutrition 90(3):485-92. — PubMed PMID: 19640950
- Cassidy A, Mukamal KJ, Liu L, Franz M, Eliassen AH, Rimm EB (2013). High anthocyanin intake is associated with a reduced risk of myocardial infarction in young and middle-aged women. Circulation 127(2):188-96. — PubMed PMID: 23319811
- Cassidy A, Bertoia M, Chiuve S, Flint A, Forman J, Rimm EB (2016). Habitual intake of anthocyanins and flavanones and risk of cardiovascular disease in men. American Journal of Clinical Nutrition 104(3):587-94. — PubMed PMID: 27488237
- Curtis PJ, van der Velpen V, Berends L, Jennings A, Feelisch M, Umpleby AM, Evans M, Fernandez BO, Meiss MS, Minnion M, Potter J, Minihane AM, Kay CD, Rimm EB, Cassidy A (2019). Blueberries improve biomarkers of cardiometabolic function in participants with metabolic syndrome — results from a 6-month, double-blind, randomized controlled trial. American Journal of Clinical Nutrition 109(6):1535-1545. — PubMed PMID: 31136659
- Teets C, Ghanem N, Ma G, Minj J, Perkins-Veazie P, Johnson SA, Etter AJ, Carbonero FG, Solverson PM (2024). A one-week elderberry juice intervention augments the fecal microbiota and suggests improvement in glucose tolerance and fat oxidation in a randomized controlled trial. Nutrients 16(20):3555. — PubMed PMID: 39458549
- Xu L, Tian Z, Chen H, Zhao Y, Yang Y (2021). Anthocyanins, anthocyanin-rich berries, and cardiovascular risks: systematic review and meta-analysis of 44 randomized controlled trials and 15 prospective cohort studies. Frontiers in Nutrition 8:747884. — PubMed PMID: 34977111
- Avendano EE, Ellingson H, Digga E, Velasco Nieves AM, Chen L, Wu M, Setty SH, Morley S, Curtis P, Nirmala N, Cassidy A (2026). Dietary intakes of anthocyanins and cardiometabolic health: a systematic review and meta-analysis of randomized trials and prospective cohort studies in healthy participants. American Journal of Clinical Nutrition 124(2):101304. — PubMed PMID: 42547104
- Olejnik A, Kowalska K, Olkowicz M, Rychlik J, Juzwa W, Myszka K, Dembczyński R, Białas W (2015). Anti-inflammatory effects of gastrointestinal digested Sambucus nigra L. fruit extract analysed in co-cultured intestinal epithelial cells and lipopolysaccharide-stimulated macrophages. Journal of Functional Foods 19:649-660. — doi:10.1016/j.jff.2015.09.064
- Olejnik A, Olkowicz M, Kowalska K, Rychlik J, Dembczyński R, Myszka K, Juzwa W, Białas W, Moyer MP (2016). Gastrointestinal digested Sambucus nigra L. fruit extract protects in vitro cultured human colon cells against oxidative stress. Food Chemistry 197(Pt A):648-57. — PubMed PMID: 26616999
- Sidor A, Gramza-Michałowska A (2015). Advanced research on the antioxidant and health benefit of elderberry (Sambucus nigra) in food — a review. Journal of Functional Foods 18:941-958. — doi:10.1016/j.jff.2014.07.012
- Veberic R, Jakopic J, Stampar F, Schmitzer V (2009). European elderberry (Sambucus nigra L.) rich in sugars, organic acids, anthocyanins and selected polyphenols. Food Chemistry 114(2):511-515. — doi:10.1016/j.foodchem.2008.09.080
- Schauss AG, Wu X, Prior RL, Ou B, Patel D, Huang D, Kababick JP (2006). Phytochemical and nutrient composition of the freeze-dried Amazonian palm berry, Euterpe oleraceae mart. (acai). Journal of Agricultural and Food Chemistry 54(22):8598-603. — PubMed PMID: 17061839
- Kopéć A, Sikora E, Piątkowska E, Borczak B, Czech T (2016). Possible protective role of elderberry fruit lyophilizate against selected effects of cadmium and lead intoxication in Wistar rats. Environmental Science and Pollution Research International 23(9):8837-48. — PubMed PMID: 26810666
- Ferreira-Santos P, Badim H, Salvador AC, Silvestre AJD, Santos SAO, Rocha SM, Sousa AM, Pereira MO, Wilson CP, Rocha CMR, Teixeira JA, Botelho CM (2021). Chemical characterization of Sambucus nigra L. flowers aqueous extract and its biological implications. Biomolecules 11(8):1222. — PubMed PMID: 34439888